EP 1372785 A2 20040102 - COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF ELETRIPTAN
Title (en)
COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF ELETRIPTAN
Title (de)
ZUSAMMENSETZUNG MIT VERBESSERTER BIOVERFÜGBARKEIT VON ELETRIPTAN
Title (fr)
COMPOSITIONS A BIODISPONIBILITE RENFORCEE D'ELETRIPTAN
Publication
Application
Priority
- GB 0105131 A 20010301
- IB 0200512 W 20020220
Abstract (en)
[origin: WO02070070A2] The bioavailabilty of eletriptan can be increased by co-administering eletriptan with a p-glycoprotein (p-gp) inhibitor. The eletriptan and p-gp inhibitor can be administered together in a composition or as separate components. If administered separately, they can be embodied as a kit.
IPC 1-7
IPC 8 full level
A61K 45/00 (2006.01); A61K 31/40 (2006.01); A61K 31/404 (2006.01); A61K 45/06 (2006.01); A61P 25/06 (2006.01); A61P 43/00 (2006.01); A61K 47/10 (2006.01); A61K 47/14 (2006.01); A61K 47/22 (2006.01); A61K 47/44 (2006.01)
CPC (source: EP)
A61K 31/40 (2013.01); A61K 45/06 (2013.01); A61P 25/06 (2017.12); A61P 43/00 (2017.12); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/22 (2013.01); A61K 47/44 (2013.01)
Citation (search report)
See references of WO 02070070A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02070070 A2 20020912; WO 02070070 A3 20030410; AU 2002232061 A1 20020919; BR 0207751 A 20040309; CA 2439917 A1 20020912; EP 1372785 A2 20040102; GB 0105131 D0 20010418; JP 2004529893 A 20040930; MX PA03007836 A 20031208
DOCDB simple family (application)
IB 0200512 W 20020220; AU 2002232061 A 20020220; BR 0207751 A 20020220; CA 2439917 A 20020220; EP 02712162 A 20020220; GB 0105131 A 20010301; JP 2002569239 A 20020220; MX PA03007836 A 20020220